Phentermine


Generic Medicine Info
Contraindications
Hyperthyroidism, history of CV disease (e.g. coronary artery disease, arrhythmias, CHF, uncontrolled HTN), glaucoma, history of alcohol/drug abuse, agitated states. Pregnancy and lactation. Concomitant or w/in 14 days of MAOI use.
Special Precautions
Patient w/ HTN, DM, seizure disorder, Tourette's syndrome. Avoid abrupt withdrawal. Renal impairment. Patient Counselling May impair ability to drive or operate machinery. Monitoring Parameters Monitor wt, waist circumference and BP.
Adverse Reactions
Urticaria, palpitation, tachycardia, elevation of BP, ischaemic events, overstimulation, restlessness, dizziness, insomnia, euphoria, tremor, headache, dry mouth, unpleasant taste, diarrhoea, vomiting, constipation, impotence, change in libido. Rarely, psychotic episodes, cardiac valvular disease.
Potentially Fatal: Rarely, primary pulmonary HTN.
Drug Interactions
Primary pulmonary HTN or valvular heart disease may occur when phentermine is used concurrently w/ fenfluramine or dexfenfluramine. May decrease hypotensive effect of adrenergic neuron blocking drugs (e.g. guanethidine, clonidine, methyldopa). CNS stimulant effect may be increased by thyroid hormones.
CIMS Class
ATC Classification
A08AA01 - phentermine ; Belongs to the class of centrally acting antiobesity products. Used in the treatment of obesity.
Disclaimer: This information is independently developed by CIMS based on phentermine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in